These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29188853)

  • 41. Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment.
    Doraiswamy PM; Goldberg TE; Qian M; Linares AR; Nwosu A; Nino I; D'Antonio J; Phillips J; Ndouli C; Hellegers C; Michael AM; Petrella JR; Andrews H; Sneed J; Devanand DP
    J Alzheimers Dis; 2022; 86(3):1131-1136. PubMed ID: 35180109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE.
    de Jager CA; Schrijnemaekers AC; Honey TE; Budge MM
    Age Ageing; 2009 Jul; 38(4):455-60. PubMed ID: 19454402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
    Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.
    Charvet LE; Shaw M; Frontario A; Langdon D; Krupp LB
    Mult Scler; 2018 Apr; 24(4):512-519. PubMed ID: 28322606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of the NIH Toolbox Cognition Battery in middle to older aged adults with longstanding type 1 diabetes: The DCCT/EDIC study.
    Chaytor NS; Trapani VR; Braffett BH; Fonseca LM; Lorenzi GM; Gubitosi-Klug RA; Hitt S; Farrell K; Jacobson AM; Ryan CM
    Clin Neuropsychol; 2024 May; 38(4):1007-1027. PubMed ID: 37814481
    [No Abstract]   [Full Text] [Related]  

  • 47. A Validation Study of the Inbrain CST: a Tablet Computer-based Cognitive Screening Test for Elderly People with Cognitive Impairment.
    Chin J; Kim DE; Lee H; Yun J; Lee BH; Park J; Yeom J; Shin DS; Na DL
    J Korean Med Sci; 2020 Aug; 35(34):e292. PubMed ID: 32864906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation.
    Stricker NH; Twohy EL; Albertson SM; Karstens AJ; Kremers WK; Machulda MM; Fields JA; Jack CR; Knopman DS; Mielke MM; Petersen RC
    Alzheimers Dement; 2023 Jun; 19(6):2575-2584. PubMed ID: 36565459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults.
    Heaton RK; Akshoomoff N; Tulsky D; Mungas D; Weintraub S; Dikmen S; Beaumont J; Casaletto KB; Conway K; Slotkin J; Gershon R
    J Int Neuropsychol Soc; 2014 Jul; 20(6):588-98. PubMed ID: 24960398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reliability, Validity, and User-Experience of Remote Unsupervised Computerized Neuropsychological Assessments in Community-Living 55- to 75-Year-Olds.
    Kochan NA; Heffernan M; Valenzuela M; Sachdev PS; Lam BCP; Fiatarone Singh M; Anstey KJ; Chau T; Brodaty H
    J Alzheimers Dis; 2022; 90(4):1629-1645. PubMed ID: 36314208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Older Black Adults' Satisfaction and Anxiety Levels After Completing Alternative Versus Traditional Cognitive Batteries.
    Gamaldo AA; Tan SC; Sardina AL; Henzi C; Guest R; Ross LA; Willingham K; Zonderman AB; Andel RA
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1462-1474. PubMed ID: 30265365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using the NIH Toolbox to Assess Cognition in Adolescents and Young Adults with Autism Spectrum Disorders.
    Solomon M; Gordon A; Iosif AM; Geddert R; Krug MK; Mundy P; Hessl D
    Autism Res; 2021 Mar; 14(3):500-511. PubMed ID: 33006263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.
    Maruff P; Thomas E; Cysique L; Brew B; Collie A; Snyder P; Pietrzak RH
    Arch Clin Neuropsychol; 2009 Mar; 24(2):165-78. PubMed ID: 19395350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.
    Maruff P; Lim YY; Darby D; Ellis KA; Pietrzak RH; Snyder PJ; Bush AI; Szoeke C; Schembri A; Ames D; Masters CL;
    BMC Psychol; 2013; 1(1):30. PubMed ID: 25566378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postoperative cognitive dysfunction: computerized and conventional tests showed only moderate inter-rater reliability.
    Radtke FM; Franck M; Papkalla N; Herbig TS; Weiss-Gerlach E; Kleinwaechter R; Wernecke KD; Spies CD
    J Anesth; 2010 Aug; 24(4):518-25. PubMed ID: 20508953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A promising cognitive screener in multiple sclerosis: The NIH toolbox cognition battery concords with gold standard neuropsychological measures.
    Manglani HR; Fisher ME; Duraney EJ; Nicholas JA; Prakash RS
    Mult Scler; 2022 Oct; 28(11):1762-1772. PubMed ID: 35531593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.